UB Paderborn / Katalog / Suche / in CDI

Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants

Journal of genetic counseling, 2024-04, Vol.33 (2), p.370-381

2024

Link zum Volltext

Verfügbarkeit prüfen

A Double-blind Randomized Trial of Wound and Intercostal Space Infiltration with Ropivacaine during Breast Cancer Surgery: Effects on Chronic Postoperative Pain

Anesthesiology (Philadelphia), 2013-02, Vol.118 (2), p.318-326

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

Breast cancer research and treatment, 2019-12, Vol.178 (3), p.505-512

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

The Lancet (British edition), 2014-06, Vol.383 (9935), p.2127-2135

2014

Link zum Volltext

Verfügbarkeit prüfen

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Genetics in medicine, 2010-12, Vol.12 (12), p.801-807

2010

Link zum Volltext

Verfügbarkeit prüfen

Brain Metastases from Breast Cancer: Recursive Partitioning Analysis of Prognostic Factors Including Molecular Subtypes and Treatment

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S4-S5

2010

Link zum Volltext

Verfügbarkeit prüfen

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

Breast cancer research : BCR, 2023-06, Vol.25 (1), p.72-72, Article 72

2023

Link zum Volltext

Verfügbarkeit prüfen

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Familial cancer, 2012-06, Vol.11 (2), p.269-278

2012

Link zum Volltext

Verfügbarkeit prüfen

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1 2 mutations

European journal of human genetics : EJHG, 2011-05, Vol.19 (5), p.500-506

2011

Link zum Volltext

Verfügbarkeit prüfen

Mutation analysis of PALB2 gene in French breast cancer families

Breast cancer research and treatment, 2015-12, Vol.154 (3), p.463-471

2015

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

Genetics in medicine, 2012-05, Vol.14 (5), p.527-534

2012

Link zum Volltext

Verfügbarkeit prüfen

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1529-1541

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results

International journal of radiation oncology, biology, physics, 2006-03, Vol.64 (4), p.1072-1080

2006

Link zum Volltext

Verfügbarkeit prüfen

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (3), p.624-638

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-21-14: Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: Real-life results from the Curie ESME database

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-14

2018

Link zum Volltext

Verfügbarkeit prüfen

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

JNCI : Journal of the National Cancer Institute, 2019-04, Vol.111 (4), p.350-364

2019

Link zum Volltext

Verfügbarkeit prüfen

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Genetics in medicine, 2021-09, Vol.23 (9), p.1726-1737

2021

Link zum Volltext

Verfügbarkeit prüfen

Medullary breast carcinoma: Prognostic implications of p53 expression

The International journal of biological markers, 2003-04, Vol.18 (2), p.99-105

2003

Link zum Volltext

Verfügbarkeit prüfen

La prise en charge des risques familiaux sans mutation

Oncologie (Paris, France), 2014-10, Vol.16 (9-10), p.425-429

2014

Link zum Volltext

Verfügbarkeit prüfen

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

British journal of cancer, 2019-07, Vol.121 (2), p.180-192

2019

Link zum Volltext

Verfügbarkeit prüfen

La prise en charge des risques familiaux sans mutation : Risques élevés de cancer du sein: quels enjeux aujourd'hui ?

Oncologie (Paris, France), 2014, Vol.16 (9-10), p.425-429

2014

Link zum Volltext

Verfügbarkeit prüfen

Re: Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

The Journal of urology, 2020-09, Vol.204 (3), p.619-620

Taneja, Samir S.

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-08-10: Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life "ESME" cohort

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-08-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Sociodemographic characteristics and sexual behavior of bisexual men in France : implications for HIV prevention

American journal of public health (1971), 1995-11, Vol.85 (11), p.1543-1546

1995

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-06-19: Large-scale retrospective analysis between 1980-2008 in 20 838 women with breast cancer - Results in young women (< 40 years old)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-06-19

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants

A Double-blind Randomized Trial of Wound and Intercostal Space Infiltration with Ropivacaine during Breast Cancer Surgery: Effects on Chronic Postoperative Pain

Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Brain Metastases from Breast Cancer: Recursive Partitioning Analysis of Prognostic Factors Including Molecular Subtypes and Treatment

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1 2 mutations

Mutation analysis of PALB2 gene in French breast cancer families

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Abstract P5-21-14: Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: Real-life results from the Curie ESME database

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Medullary breast carcinoma: Prognostic implications of p53 expression

La prise en charge des risques familiaux sans mutation

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

La prise en charge des risques familiaux sans mutation : Risques élevés de cancer du sein: quels enjeux aujourd'hui ?

Re: Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Abstract P6-08-10: Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life "ESME" cohort

Sociodemographic characteristics and sexual behavior of bisexual men in France : implications for HIV prevention

Abstract P3-06-19: Large-scale retrospective analysis between 1980-2008 in 20 838 women with breast cancer - Results in young women (< 40 years old)

Suchergebnisse filtern